Literature DB >> 23368884

Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif.

Florence F Wagner1, David E Olson, Jennifer P Gale, Taner Kaya, Michel Weïwer, Nadia Aidoud, Méryl Thomas, Emeline L Davoine, Bérénice C Lemercier, Yan-Ling Zhang, Edward B Holson.   

Abstract

Hydroxamic acids were designed, synthesized, and evaluated for their ability to selectively inhibit human histone deacetylase 6 (HDAC6). Several inhibitors, including compound 14 (BRD9757), exhibited excellent potency and selectivity despite the absence of a surface-binding motif. The binding of these highly efficient ligands for HDAC6 is rationalized via structure-activity relationships. These results demonstrate that high selectivity and potent inhibition of HDAC6 can be achieved through careful choice of linker element only.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23368884     DOI: 10.1021/jm301355j

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  28 in total

1.  Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome.

Authors:  Alan P Kozikowski; Sida Shen; Marta Pardo; Maurício T Tavares; Dora Szarics; Veronick Benoy; Chad A Zimprich; Zsófia Kutil; Guiping Zhang; Cyril Bařinka; Matthew B Robers; Ludo Van Den Bosch; James H Eubanks; Richard S Jope
Journal:  ACS Chem Neurosci       Date:  2018-12-14       Impact factor: 4.418

2.  Entropy as a Driver of Selectivity for Inhibitor Binding to Histone Deacetylase 6.

Authors:  Nicholas J Porter; Florence F Wagner; David W Christianson
Journal:  Biochemistry       Date:  2018-05-18       Impact factor: 3.162

3.  Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome Inhibitor.

Authors:  Sanil Bhatia; Viktoria Krieger; Michael Groll; Jeremy D Osko; Nina Reßing; Heinz Ahlert; Arndt Borkhardt; Thomas Kurz; David W Christianson; Julia Hauer; Finn K Hansen
Journal:  J Med Chem       Date:  2018-11-08       Impact factor: 7.446

4.  Histone Deacetylase 6-Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity.

Authors:  Nicholas J Porter; Jeremy D Osko; Daniela Diedrich; Thomas Kurz; Jacob M Hooker; Finn K Hansen; David W Christianson
Journal:  J Med Chem       Date:  2018-08-17       Impact factor: 7.446

Review 5.  Visualizing epigenetics: current advances and advantages in HDAC PET imaging techniques.

Authors:  C Wang; F A Schroeder; J M Hooker
Journal:  Neuroscience       Date:  2013-09-17       Impact factor: 3.590

6.  Hydroxamate-based histone deacetylase inhibitors can protect neurons from oxidative stress via a histone deacetylase-independent catalase-like mechanism.

Authors:  David E Olson; Sama F Sleiman; Megan W Bourassa; Florence F Wagner; Jennifer P Gale; Yan-Ling Zhang; Rajiv R Ratan; Edward B Holson
Journal:  Chem Biol       Date:  2015-04-16

7.  Discovery of a Novel HDAC2 Inhibitor by a Scaffold-Merging Hybrid Query.

Authors:  Nikita Basant; Xionghao Lin; Terry-Elinor Reid; Pradeep K Karla; Xiang S Wang
Journal:  Comb Chem High Throughput Screen       Date:  2015       Impact factor: 1.339

8.  Design, synthesis, and evaluation of hydroxamic acid-based molecular probes for in vivo imaging of histone deacetylase (HDAC) in brain.

Authors:  Changning Wang; Thomas E Eessalu; Vanessa N Barth; Charles H Mitch; Florence F Wagner; Yijia Hong; Ramesh Neelamegam; Frederick A Schroeder; Edward B Holson; Stephen J Haggarty; Jacob M Hooker
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-12-15

9.  Structural Requirements of HDAC Inhibitors: SAHA Analogues Modified at the C2 Position Display HDAC6/8 Selectivity.

Authors:  Ahmed T Negmeldin; Geetha Padige; Anton V Bieliauskas; Mary Kay H Pflum
Journal:  ACS Med Chem Lett       Date:  2017-02-07       Impact factor: 4.345

Review 10.  Small molecule inhibitors of zinc-dependent histone deacetylases.

Authors:  Florence F Wagner; Michel Weїwer; Michael C Lewis; Edward B Holson
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.